968
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up study

, , , , , , , , , , , & show all
Article: 2344589 | Received 26 Feb 2024, Accepted 10 Apr 2024, Published online: 02 May 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.